BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 19210207)

  • 1. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
    Borghi C; Cicero AF
    Clin Drug Investig; 2010; 30(12):843-54. PubMed ID: 20923243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].
    Laganović M
    Lijec Vjesn; 2010; 132(3-4):94-8. PubMed ID: 20540436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-dose combination lercanidipine/enalapril.
    Hair PI; Scott LJ; Perry CM
    Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF; Gerocarni B; Rosticci M; Borghi C
    Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
    Barrios V; Escobar C; Echarri R
    Vasc Health Risk Manag; 2008; 4(4):847-53. PubMed ID: 19066001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.